Apellis Pharmaceuticals
APLS
$40.33
Share price
-3.98%
Change (1 day)
-54.82%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) - Net assets
Net assets on the balance sheet as of March 2024 : $0.26 B
According to Apellis Pharmaceuticals's latest financial reports the company has $0.26 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Apellis Pharmaceuticals - Net assets on balance sheet (from 2014 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.19 B | 14.51% |
| 2022-12-31 | $0.16 B | -14.49% |
| 2021-12-31 | $0.19 B | -2.88% |
| 2020-12-31 | $0.20 B | 497.61% |
| 2019-12-31 | $34.22 M | -78.74% |
| 2018-12-31 | $0.16 B | 8.08% |
| 2017-12-31 | $0.14 B | 525.96% |
| 2016-12-31 | $23.79 M | -31.97% |
| 2015-12-31 | $34.97 M | 164.48% |
| 2014-12-31 | $13.22 M | 192.42% |
| 2013-12-31 | $4.52 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.32 B | 23.24% | 🇺🇸 USA |